Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2013

Nov 5, 2013

30786_dirs_2013-11-05_44f29c17-4c06-4bb2-98a6-44e572eff522.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2013-11-04

Reporting Person: GOETZ JOHN (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-04 Bio-Rad A Common Stock M 240 Acquired 44396.9995 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-04 Restricted Stock Units $0 M 240 Disposed Bio-Rad A Common Stock (240) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 58.7668 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on 9/30/2013.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest in five equal annual installments beginning November 4, 2012.